Back
  1. Home
  2. Profile of Françoise Tassin (ULiège)
Profil

Tassin Françoise

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Keutgens, Aurore  (15)
Gothot, André  (14)
Foguenne, Jacques  (12)
Beguin, Yves  (7)
Fillet, Georges  (7)
Main Referenced Keywords
Humans (7); Male (6); Aged (5); Female (4); Middle Aged (4);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (1)
Main Referenced Disciplines
Hematology (24)
Laboratory medicine & medical technology (3)
Genetics & genetic processes (3)
Immunology & infectious disease (1)
Neurology (1)

Publications (total 31)

The most downloaded
932 downloads
Delanaye, P., Bovy, C., de Leval, L., Fassotte, M.-F., Witvrouw, N., Dechenne, C., Tassin, F., & Krzesinski, J.-M. (2004). Back pain and renal failure. The Lancet, 364 (9449), 1992. doi:10.1016/S0140-6736(04)17484-9 https://hdl.handle.net/2268/7184

The most cited

45 citations (Scopus®)

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x https://hdl.handle.net/2268/8044

Pitti, P., Tassin, F., & Keutgens, A. (21 March 2023). Apport des automates d’hématologie (Sysmex XN-Series) dans le diagnostic rapide du paludisme : à propos de deux cas. Annales de Biologie Clinique, 81 (N° 2/mars-avril 2023), 189-97. doi:10.1684/abc.2023.1791
Peer Reviewed verified by ORBi

NIZET, A., FOGUENNE, J., GOTHOT, A., TASSIN, F., & KEUTGENS, A. (19 November 2021). Case report: Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19 [Poster presentation]. Annual Meeting of the Royal Belgian Society of Laboratory Medicine, Bruxelles, Belgium.

NIZET, A., FOGUENNE, J., Gothot, A., TASSIN, F., & KEUTGENS, A. (2021). Laboratory divergences in concurrent diagnosis of acute myeloid leukemia relapse and COVID-19: A case report. International Journal of Laboratory Hematology, 1-2. doi:10.1111/ijlh.13553
Peer Reviewed verified by ORBi

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., & GOTHOT, A. (May 2018). Implementation of fully automated specimen processing and data acquisition for flow cytometric immunophenotyping [Poster presentation]. XXXst International Symposium on Technological Innovations in Laboratory Hematology, Bruxelles, Belgium.

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., & GOTHOT, A. (May 2018). Implementation of fully automated specimen processing and data acquisition for flow cytometry immunophenotyping [Paper presentation]. XXXst International Symposium on Technological Innovations in Laboratory Hematology, Bruxelles, Belgium.

DARCIS, G., Van der Auwera, G., GIOT, J.-B., Hayette, M.-P., Tassin, F., Arrese Estrada, J., Cnops, L., Moutschen, M., de Leval, L., & LEONARD, P. (07 July 2017). Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC Infectious Diseases, 17. doi:10.1186/s12879-017-2571-x
Peer Reviewed verified by ORBi

LADANG, A., SIMUL, M., SOMJA, J., FOGUENNE, J., GOTHOT, A., KEUTGENS, A., & TASSIN, F. (February 2017). Richter syndrome with plasmablastic lymphoma [Paper presentation]. 32nd General Annual Meeting 2017, Bruxelles, Belgium.

LADANG, A., SIMUL, M., SOMJA, J., FOGUENNE, J., GOTHOT, A., KEUTGENS, A., & TASSIN, F. (February 2017). Unconventional richter syndrome with plasmablastic transformation [Poster presentation]. 32nd General Annual Meeting 2017, Bruxelles, Belgium.

GOSSET, C., FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., & GOTHOT, A. (2017). Automatic clustering of cell populations characterized by immunophenotyping [Poster presentation]. 32nd General Annual Meeting 2017, Bruxelles, Belgium.

KEUTGENS, A., Foguenne, J., Gothot, A., & Tassin, F. (2016). Lymphocytoses B monoclonales : de la revue de la littérature à la pratique de laboratoire. Annales de Biologie Clinique, 74 (2), 168-175. doi:10.1684/abc.2016.1127
Peer Reviewed verified by ORBi

BODART, O., MALAISE, D., Horta, A., SID, S., & TASSIN, F. (2016). An unusual cause of diplopia. Acta Neurologica Belgica. doi:10.1007/s13760-016-0647-9
Peer Reviewed verified by ORBi

KEUTGENS, A., FOGUENNE, J., Gothot, A., & TASSIN, F. (August 2015). Atypical plasma cells with coexpression of myeloid markers and bundles of Auer rod-like inclusions. International Journal of Laboratory Hematology, 37 (4), 85-6. doi:10.1111/ijlh.12322
Peer Reviewed verified by ORBi

FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology.
Peer Reviewed verified by ORBi

CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233
Peer Reviewed verified by ORBi

Louis, C., FOGUENNE, J., KEUTGENS, A., Tassin, F., & GOTHOT, A. (2014). Validation of paroxysmal nocturnal hemoglobinuria detection by flow cytometry [Poster presentation]. European Association for Professional in Biomedical Science, Dublin, Ireland.

Louis, C., FOGUENNE, J., KEUTGENS, A., Tassin, F., & GOTHOT, A. (2014). Détection de l'hémoglobinurie paroxystique nocturne par cytométrie en flux : Validation. Revue de l'Association Belge des Technologues de Laboratoire, 41 (3), 240.

HAFRAOUI, K., CAERS, J., TASSIN, F., & Beguin, Y. (2013). Hematological and molecular responses in a case of refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) treated by Lenalidomide [Poster presentation]. BHS 28th General Annual Meeting, Gent, Belgium.

HO, T. T. G., KEUTGENS, A., HUWART, A., TASSIN, F., & GOTHOT, A. (October 2011). Analyse automatisée des liquides de ponction et des liquides céphalorachidiens: Evaluation du Sysmex XE-5000. Immuno-Analyse and Biologie Spécialisée, 26, 256-263. doi:10.1016/j.immbio.2011.10.001
Peer reviewed

Thielen, C., Bisig, B., Gofflot, S., Herens, C., Fillet, G., JAMAR, M., Tassin, F., Boniver, J., Drion, P., & de Leval, L. (2011). CHIC cells: a novel ALK+ cell line derived from a relapsed anaplastic large cell lymphoma. British Journal of Haematology, 152, 356-360. doi:10.1111/j.1365-2141.2010.08414.x
Peer Reviewed verified by ORBi

Herens, C., Ketelslegers, O., Tassin, F., Hansen, S., & Bours, V. (2006). Inositide-specific phospholipase c beta1 gene deletion is a rare event in myelodysplastic syndromes. Leukemia, 20 (3), 521-2; author reply 522-3. doi:10.1038/sj.leu.2404109
Peer Reviewed verified by ORBi

Delanaye, P., Bovy, C., de Leval, L., Fassotte, M.-F., Witvrouw, N., Dechenne, C., Tassin, F., & Krzesinski, J.-M. (2004). Back pain and renal failure. The Lancet, 364 (9449), 1992. doi:10.1016/S0140-6736(04)17484-9
Peer Reviewed verified by ORBi

Herens, C., Baron, F., Croisiau, C., Tassin, F., & Bours, V. (2003). Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases. Cancer Genetics and Cytogenetics, 147 (1), 78-80. doi:10.1016/S0165-4608(03)00198-5
Peer Reviewed verified by ORBi

Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442
Peer Reviewed verified by ORBi

Tassin, F., Dewé, W., Schaaf-Lafontaine, N., Herens, C., Ravoet, C., Albert, A., Beguin, Y., & Paulus, J.-M. (2000). A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes. Leukemia and Lymphoma, 36 (5-6), 485-96. doi:10.3109/10428190009148396
Peer Reviewed verified by ORBi

Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x
Peer Reviewed verified by ORBi

Herens, C., Hermanne, J.-P., Tassin, F., Fassotte, M.-F., Thiry, A., Jamar, M., Schaaf-Lafontaine, N., Fillet, G., & Koulischer, L. (1999). Translocation (2;3)(p21;q26) as the sole anomaly in a case of primary myelofibrosis. Cancer Genetics and Cytogenetics, 110 (1), 62-4. doi:10.1016/S0165-4608(98)00186-1
Peer Reviewed verified by ORBi

Smitz, S., Neven, I., Sautois, B., & Tassin, F. (1999). L'image du mois. Purpura thrombocytopenique auto-immun. Revue Médicale de Liège, 54 (8), 645.
Peer reviewed

Tassin, F., Hermanne, J.-P., Schaaf-Lafontaine, N., Herens, C., Thiry, A., Paulus, J.-M., Boniver, J., & Fillet, G. (June 1998). Les syndromes myélodysplasiques: syndromes préleucémiques. Revue Médicale de Liège, 53 (6), 357-62.
Peer reviewed

Hermanne, J.-P., Tassin, F., Bours, V., & Fillet, G. (March 1996). Rétinoïdes et leucémie aigue promyelocytaire. Une révolution thérapeutique. Revue Médicale de Liège, 51 (3), 217-23.
Peer reviewed

Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489.
Peer Reviewed verified by ORBi

Hermanne, J.-P., TASSIN, F., Bours, V., & Fillet, G. (1996). Intérêt de l'acide rétinoïque "tous trans" dans le traitement de la leucémie aiguë promyélocytaire. Médecine et Hygiène, 54, 1472-1479.
Peer Reviewed verified by ORBi

Contact ORBi